Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

AIMS: Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value of 77 b.p.m. is the lower bound selected for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Bouabdallaoui, Nadia, O'Meara, Eileen, Bernier, Virginie, Komajda, Michel, Swedberg, Karl, Tavazzi, Luigi, Borer, Jeffrey S., Bohm, Michael, Ford, Ian, Tardif, Jean‐Claude
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989297/
https://ncbi.nlm.nih.gov/pubmed/31591826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12513
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars